DocuSign beat Q4 estimates and crossed $1B in annual free cash flow. IAM ARR was formally quantified for the first time at $350M (10.8% of total). All six analysis signals were confirmed at their previous assessments — no label changes. The moat trajectory was upgraded from “weakly negative” to “stabilizing” as Microsoft shifts from potential competitor to active channel partner. After incorporating the quarter across all forecast markets, we have maintained the LEANING_BULL classification at MEDIUM confidence. At $49 and 9.3x P/FCF, the market prices in zero IAM optionality.
The Numbers: Solid Beat, First $1B FCF Year
Q4 FY2026 revenue of $837M (+8% YoY) beat consensus by approximately $9M. Non-GAAP EPS of $1.01 exceeded the $0.95 consensus. Q4 billings crossed $1B for the first time. Full-year free cash flow reached $1,058.6M (33% margin), marking the first fiscal year above $1B, underscoring the cash generation strength of the e-signature base business.
Total ARR reached $3,272M (+8%) with dollar net retention improving to 102%, the sixth consecutive quarter of improvement. FY2027 guidance came in at $3.48-3.50B revenue (+8%), maintaining the steady-state growth trajectory. Management also announced a $2B buyback increase (bringing total authorization to $2.6B), signaling confidence in the cash flow durability.
The headline number: IAM ARR was formally quantified at $350M+ for the first time, representing 10.8% of total ARR. Management set a target of 18% of ARR by the end of FY2027 (~$600M+). This moves IAM from aspirational narrative to measurable business segment.
Signal Confirmation: All 6 Unchanged, Trajectories Improving
Our 6-lens analysis produced no signal reclassifications; every label held. Several sub-signal trajectories shifted positively, particularly around competitive positioning and revenue evidence quality:
The sharpest sub-signal shift: the moat trajectory moved from “weakly negative” to “stabilizing” as Microsoft pivots from potential competitor to active channel partner. The Microsoft threat level was downgraded from MEDIUM to LOW-MEDIUM. Meanwhile, Revenue Revealer confidence increased from MEDIUM to MEDIUM-HIGH now that IAM has E2-level evidence (formally quantified ARR) rather than anecdotal references. SBC as a percentage of revenue declined from 20.5% to 19.3%, contributing to the narrative gap narrowing.
Prediction Scorecard: 4 Resolved, Avg Brier 0.16
Four markets resolved this quarter: three with strong calibration and one miss. Average Brier score of 0.16 across the batch:
The billings market was the clear miss: the ensemble assigned only 30% probability to ≥10% billings growth, and DocuSign delivered it. Q4 billings of $1.01B exceeded the threshold. This suggests our models were too anchored to the 8% revenue growth rate and underweighted the billings seasonality and deal timing dynamics that characterize DocuSign's Q4.
Management Rhetoric: Optimism With Guardrails
The earnings call language was carefully calibrated. CEO Allan Thygesen described the company as “positioned to begin accelerating the business” while guiding for 8% growth, the same rate as FY2026. The CFO was more direct on the double-digit growth question: “long-term aspiration... The when on that is not as important to me.” This is management explicitly managing expectations downward while the operational metrics move upward, a pattern more consistent with eventual upside surprises than overpromise.
On IAM retention, the CFO offered “cautiously optimistic... very early days... sample size is pretty small.” On AI, the CEO highlighted DocuSign's “huge advantage in using private consented agreements, not just public data”, positioning the agreement corpus as a defensible AI moat. This framing is credible: 1.5 million customers generating structured agreement data is a genuinely differentiated dataset that general-purpose AI models cannot replicate.
Thesis Assessment: LEANING_BULL Maintained
Classification unchanged: LEANING_BULL at MEDIUM confidence. The central question remains: does IAM reach 20%+ of revenue with proven retention differential? Q4 moved the needle (IAM now quantified, moat trajectory stabilizing, valuation further compressed), but not enough to change either the label or the confidence level.
The factors preventing an upgrade to HIGH confidence: (1) IAM at 10.8% is still well below the 20% threshold where revenue durability transitions from conditional to structural, (2) the GOVERNANCE_ALIGNMENT signal remains at MIXED with no new Form 4 insider data, and (3) the CFO's own language (“very early days,” “sample size is pretty small”) suggests the IAM retention data is not yet robust enough to anchor a higher-confidence assessment.
What to Watch Next
Full thesis assessment with market-by-market analysis, signal table, resolved market calibration, and key monitoring triggers
DOCU Full Thesis Assessment